Conference, brokerage event, workshops, start-up pitches - Enjoy Meet in Italy for Life Sciences 2019
See the program here: https://meetinitalylifescience...
See the program here: https://meetinitalylifescience...
Some examples of collaborative public and private R&D Innovative Projects in Life Science sector realized in the Friuli Venezia Giulia Region thanks to European Funds - ERDF ROP 2014-2020, will be presented. The Region FVG has invested about 17 Mln euro in 34 collaborative projects. The main project topics, in line with the strategic technological priorities of the FVG Region, defined during the S3 process, focus on biomedical and in vivo and in vitro diagnostic technologies, medical informatics and bioinformatics, personalized medicine and the Ambient Assisted Living technologies. During the MIT4LS2019, the following five projects will be presented:
- ARES-Against bRain cancEr: finding personalized therapies with in Silico and in vitro strategies;
- BIOfilm Sensing and Analysis For hEalth – BIOSAFE;
- DOMINO-Innovative Molecular Hospital Diagnostics in NGS for Oncology;
- PREDITT-Thyroid Cancer Prediction;
- TICHEP-Innovative Technologies for Personalized Chemotherapy.
For too long, the role of diagnostics has been underestimated, favoring the healing aspect as the crucial moment of a patient’s treatment. In the last fifteen years, however, we have seen a gradual paradigm shift that has granted prevention and diagnostics an increasingly important role in the governance of advanced countries’ health care policies. It is now evident that preventive diagnostics means ensuring, together with more effective and personalized care, an ever-improved quality of life for patients. If prevention means applying healthy lifestyles in a sustainable environment, performing a successful diagnosis means knowing how to best integrate all of the available tools for the most effective interpretation of data. Radiomics is one such example. The Bracco Group has accepted the challenge, putting research projects capable of delivering concrete answers into play.
Functional foods are products of the food industry that possess proven physiological benefits that go beyond their nutritional role thanks to their natural enrichment in specific beneficial active ingredients. Food supplements are products developed by the pharmaceutical industry that contain active nutritional ingredients derived from food, in the form of pills, capsules or sachets. Both products can be classified as "nutraceuticals", a term created in 1989 by Joseph De Felice to understand a symbiosis between nutrition and pharmaceuticals. Nutraceuticals represent a new consumer sector in which the Italian pharmaceutical industry and the food industry are investing heavily to provide effective solutions for improving health or reducing the risk of disease through prevention. In this sector, Italy is second only to the United States in terms of scientific production and can boast an enlightened vision that does not limit itself to considering food supplements as nutraceutical but enhances the natural constituents of our quality regional foods and boasts extraordinary development potential, both for the presence of numerous natural products and for the industry's ability to formulate very pleasant and potentially effective products.
ITHACA is an Interreg Europe project that involves nine regions that share experiences and good practices on smart health and care innova¬tion, to improve active and healthy ageing of the population. A key aim is to refine regional policies in order to sup¬port innovative businesses, create growth and scale up the deployment of innovative health and care solutions. Through ITHACA the partner regions will:
• Improve their regional development and smart spe¬cialisation policies and make them more effective.
• Improve learning cultures and knowledge for all stakeholders in the smart health and care ecosys¬tems - bringing about real change to policy, prac¬tice and impact.
Application of nanotechnology to medical science has been emerging as a new interdisciplinary and cutting-edge area of biomedical research. It involves the development of novel engineered nanomaterials expected to have a relevant impact on the prevention, diagnosis and treatment of several diseases. Over the last decade, many efforts have been devoted to the development of both new molecular nano-biosensor technologies and nano architectures to release bioactive compounds for therapeutic purposes. This Workshop will present innovative results obtained in Biosensors and therapeutic Approaches using the micro and nanotechnologies.
The cells of our body are constantly inflamed. There are some plant origin compounds exercising an anti-inflammatory action. Based on these two statements, the study presented by Biofarma, in collaboration with the Department of Medicine of the University of Udine, aims to measure the different activity of these vegetable substances. The purpose is to understand which is actually contributing to the physiological control of inflammation, if inserted in a food supplement.
Silver Economy Network, SEN - the first network of companies offering services and products for the over 65, in collaboration with G2-Startups – Innovation Lab, Business and Startup Accelerator, launch Digital Health Lab initiative, an innovation laboratory and path designed to help business address innovation in the Health Industry. The workshop is the first meeting of Digital Health Lab path. The lab promotes contamination between business and external sources of innovation (in particular start-ups) and helps to understand organizational impacts, skills and technologies required in order to innovate. An active laboratory designed to bring ideas and innovation projects to life.
Biomaterials for implants and regenerative medicine is one of the most fascinating research fields where the most challenge goal is to develop smart nanomaterials to trigger the regenerative powers of our bodies to restore diseased tissue and organs and/or prevent degeneration.
Physiological sensors are the new frontier in automotive technologies for Advanced Driver Assistance Systems and current research aims to develop innovative micro-technologies to monitor in real-time the driver's psycho-physiological and drowsiness.
In this workshop, we will present a survey on the most innovative approaches in bone tissue regeneration and Physiological sensors for driver drowsiness control.
This Interreg Italia Slovenia Project aims to improve the quality of life of patients making available new therapies and to open up entrepreneurial and investment opportunities in this fast-growing global market (estimated to reach € 7.2 € Bn by 2025). The initial focus is a treatment for knee Osteoarthritis.
The workshop will discuss methods and innovations to bring breakthrough therapies to patients and new technologies to market to improve healthcare sustainability and to spur investments.
The theme of the workshop is Innovation Circle, a physical space within Bio4Dreams where the different key players of the technology transfer value chain in Life Sciences (innovation hub, universities and research centers, incubators, investors and companies) join their efforts, networks and skills to speed up the development of the most promising innovative startups.
TRAIN is an INTERREG project focused on big data and disease models, which fosters cross border cooperation between scientists and industry in the biomedical field. We will present three focal research areas which represent great opportunities for industry application to improve both diagnosis and disease therapy. Speakers will discuss the use of "disease in a dish" models to study human disease, drug development, and high throughput screening. At our stand you will have the opportunity to experience this process first hand in a unique virtual reality presentation, discovering treatments and administering them to a patient to see their therapeutic effect.
The demand of rapid and reliable clinical tests pushes Alifax to investigate new fields as molecular biology and spectroscopy to develop new IVD devices. Alifax is in collaboration with world known research institutions and universities to cope the most promising innovations with the manufacture sector demands. In this contribute we aim to present an overview of our instruments and current R&Ds projects with potential impact on the market in next years. Researchers and International Scientists will present the State of the Art in the fields now explored by Alifax and report the potential analytical performances and benefits for Hospitals and Community.
During the workshop it will be given a keen overview about:
- Changes in the lifescience industry
- Community health centers and general practitioners
- National Continuously Medical Education Platform (NCME)
- Technology transfer and local distribution, new trends with specific interest towards advanced techonlogy and artificial intelligence managed rehab systems and devices.
The mission: to accelerate the interaction between research and industry, also with the help of the world of finance. The event is an opportunity designed for this purpose to create synergies and collaborations with companies. In particular, La Sapienza expresses excellence in the field of technological and scientific research, which have a high impact on new technologies. A world to be valued and connected to the production context. Therefore, representatives of the Confindustrial world and important local entrepreneurs will be invited in order to present an important partnership in support of technology transfer, innovation, training and job placement.
It’s time to rewrite the rules of business and innovation! Thanks to our exclusive Agile Research Framework we can supply prototypes to the industry ready to become successful products.
Agile Research Framework is a rigorous search model, Just in Time and of correct size, which seeks to minimize the burden while maximizing the value of the research process and results for interested parties.
The advantages we offer to companies are: risk reduction, product time-to-market improvement and maximum investment efficiency. Furthermore, Innova Partners S.p.A. is an innovative start-up, so the R&D investments made with us are valid for the italian tax credit
A ground-breaking approach for the treatment of cystitis with a new solution based on high molecular weight Hyaluronic Acid (2 million Dalton) in an innovative plastic bag equipped with an auxiliary nozzle which provides the advantage of a combined therapy with a single injection to the patient via catheter.
An example of biotech innovation in both Medical and Device fields.
Using hepatocellular carcinoma as a Proof of Concept, image stacks from clinical patients are first converted into a Finite Element Methods volume. Then our mathematical engine is applied to virtualize tumor proliferation and selected most promising therapy. Empowered by Augmented Reality gears, CancerMate supports oncologists, surgeons, pharma and imaging device researchers.
DataRiver develops innovative software solutions for the integration and analysis of Big Data for Pharmaceutical and Biotech Companies, Clinical Research Institutes and Hospitals. Several success stories using Big Data and Machine Learning technologies will be presented:
• I-DAP platform for medical device safety monitoring provides a unified view of all available medical device safety data
• The MyHealth mobile platform ensures effective interaction between medical staff and patients and offers new opportunities to monitor the health and quality of life of patients.
EIT Health is a network of best-in-class health innovators backed by the EU.
-€90 million in investment attracted by start-ups, 400 start-ups supported, 21 000 professionals and graduates trained and 35 solutions brought to market.
-We INCUBATE ideas We VALIDATE concepts We SCALE businesses.
The workshop will present EIT Health programmes for innovative Startup in healthcare. Startup who have ideas with great potential but who do not have the capital, experience or resources to bring their solution to the regulators and reimbursement bodies.
In this MIT4LS2019 edition, some Universities and International Research Institutes of the Cluster Smart Health of the Friuli Venezia Giulia region will be presented.
The University of Trieste, the SISSA-International School of Advanced Studies of Trieste, the academic medical center hospital – ASUI TS-Azienda Sanitaria Universitaria Integrata of Trieste - certified by the Joint Commission International (JCI), the 2 Scientific Research and Healthcare Institutes (IRCCS), the Child Hospital Burlo Garofolo of Trieste and the Oncological Hospital CRO-Centro di Riferimento Oncologico of Aviano, the ICGEB-International Centre for Genetic Engineering and Biotechnology and the Elettra Sincrotrone Trieste will present their Research&Innovation Projects and activities, and their Technology Transfer strategies in the Life Sciences.
In a competitive and rapidly evolving sector such as the pharmaceutical and biomedical ones, it is of fundamental importance to protect the image and the results of scientific research in the most effective way possible. The speakers will illustrate the best strategies and ways to achieve an adequate protection, focusing on the main tools of protection: patents, designs and trademarks.
At Department of Chemical Sciences and Materials Technologies (DSCTM) and Department of Biomedical Sciences DSB at Italian National Research Council (CNR) we implement crosscutting approaches to various fields of chemical and biomedical research. The molecular mechanisms of ageing, the genetic susceptibility to diseases, the early diagnosis and epidemiological aspects of ageing, are among the biggest challenges.
We provide innovative tools, requiring life science “big data” analysis, for the identification of putative targets for effective therapeutic approaches. We develop new predictive and prognostic biomarkers for clinical applications.
The search for funding sources to support own innovation activities is now extremely competitive and requires specific skills, multi-disciplinarity and vision. The workshop is open to entrepreneurs, managers, researchers from clinical centers, universities, institutions and private companies; it aims to present some case histories useful for directing private companies and public research institutes towards success and wants to stimulate the participation and the questions of the participants for an open discussion on concrete cases.
The Chinese group TONG REN TANG opens up to the European market for the first time and has chosen GIOMI to do so. With this ambitious project, Italy sees its recognized excellence in the world rewarded and, through the Italian-Chinese joint venture, it will be possible to lay the foundations for the future creation of a world health player with significant implications in the world of research and treatment.
The common path undertaken by the two corporate groups has in fact the objective of spreading well-being through health-care methodologies that until yesterday diverged in traditions and techniques and the newco, in particular, will promote not only traditional Chinese medicine products in the Italian and European markets, but plans to open pharmacies, specialized parapharmacies, traditional Chinese medicine centers with a modern management organization, clinics and departments to accommodate the flow of patients in reserved spaces within the GIOMI group hospital facilities.
Worldwide, every 3 seconds someone breaks a bone due to osteoporosis. Osteoporosis is a silent huge problem, affecting more than 75M people in the EU6. About 62% of those at risk don’t know it until their fracture. Also, many that are it at risk are given unnecessary medications. In Europe, 37 B€ is the annual cost to cover the post-‐fracture recovery and the unnecessary drugs. There is a market opportunity that is worth 500 Million annually for a safe new test increasing from 60 to 90% your chance to get a correct diagnosis. That test is the BES TEST, Bone Elastic Structure Test. With an innovative engineering approach, BES TEST MEASURES the QUALITY OF BONE MICRO ARCHITECTURE.
After years of lack of communication between physics and life sciences, today something is changing: doctors choose a more physical and quantitative approach, and physicists accept the challenge posed by the complexity of life.
During the workshop we will show and discuss examples of interactions between physics, biology and medicine, reviewing the tools and methods used (algorithms, spectral investigations, nanotechnologies ...)
Health and wellbeing companies constantly need to acquire skills and competences to drive the innovation of their products and processes. In particular, the new rules of the regulatory system, the economic aspects, the research management need to be tackled by new professional figures and human resources able to ensure an effective market access and address the innovation challenge.
This implies that the professional figures required by companies, or even the continuous training that companies must provide for their employees, must be reflected in a training system capable of giving timely responses and drawing up programs in line with these needs.
In this respect, the cluster organizations of the Life Science sector of Emilia-Romagna, Tuscany and Friuli Venezia Giulia will compare experiences, in order to enable a further advancement of the respective ecosystems, also enhancing the role that regional clusters should have in anticipating the needs that their associates can express.
Translation of research results into practical applications is central to the ICGEB mission, in line with the growing international recognition that biotechnology can offer practical solutions to major global challenges in the health, agriculture and energy fields. The Biotechnology Development Unit (BDU) in Trieste focuses on the development and transfer of technologies for the production of biosimilars (off-patent recombinant proteins), with the aim of enhancing the capacity of the pharmaceutical industries in ICGEB Member States. A large grant received in 2018 from the FVG Region to upgrade the BDU facility will allow a significant expansion of its activities, including the provision of enhanced Quality Control services and the maintenance of GMP recombinant cell lines. During the workshop the BDU will outline its expertise and technology platforms. Other technologies developed at the ICGEB Trieste will also be presented. Among these, the Bacteriology lab will display its “Strains for Plants” project, focused on the identification of novel bacterial strains tailored to be used as biopesticides and/or biofertilizers, crucial for promoting a more sustainable agricolture.
At its fifth edition, EURO BioHighTech, with the organization of a "Meet In Italy" session, presents the advantages for citizens that arise from innovation in the Smart Health sectors. The direct connection and the coordinated work of the Research & Innovation Projects with the business world, including cross-border, of companies that produce and sell innovative products in the Biomedical, Biotechnological and Bioinformatics sectors, have allowed to explore new opportunities for development and well-being for citizens of the Alpe-Adria Area.
Thanks to the European funding connected to the "Intelligent Specialization" of the Friuli Venezia Giulia Region, the Research bodies and regional Companies that are members of the BioHighTech NET Network, of the Chamber of Commerce and/or of the Confindustria of Venezia Giulia, present the most successful R&D projects.
Worried about your elders living alone? Teseo’s first product, Kibi, is designed to assist elderly people in both domestic and elderly care environments. Using a smartwatch and sensors, Kibi allows caregivers to be constantly informed in case of emergencies and produce detailed reports on the health and independence levels of the assisted person based on their habits. Teseo is an assistive technology startup and spin-off of the University of Genova, IT.
Elettra Sincrotrone Trieste is an international multidisciplinary research center of excellence specialized in the generation of synchrotron light for applications in the field ofmaterials sciences and life sciences. The centre hosts, together with several specialized laboratories, state-of-the-art analysis techniques based on the use of X-rays in the area sof spectroscopy, spectromicroscopy, diffraction and scattering, as well as beamlines of microscopy and radiation spectroscopy infrared and ultraviolet. The workshop will focus on the main competences and the most relevant scientific and applied research activities in the pharmaceutical, biomedical and biomaterial fields.